News/Events

The Future of Medicine

September 23, 2015

Neal Woodbury, Co-Director, Biodesign’s Center for Innovations in Medicine Considering new medical diagnostics, genetic sequencing, protein analyses, fitness devices and even our Internet search histories, how will these new insights change the relationships between doctors and patients, and between people and the health care system? More information Download flier

ASU proves its patent prowess with global ranking

June 17, 2015

Michael Kozicki is no stranger to patents. The Arizona State University professor – who has 50 here in the U.S. and about 30 foreign equivalents – has had so many significant patents that he was inducted into the National Academy of Inventors in March. That was no easy feat, he said. “You have to be an evil genius, basically,” said Kozicki, who is with the School of Electrical, Computer and Energy Engineering in the Ira A. Fulton Schools of Engineering. “You have to have...

ASU spinout HealthTell among top five "start-ups to watch"

January 28, 2015

ASU Biodesign Institute spinout, HealthTell, landed on San Francisco Business Times reporter Ron Leuty's top five start-ups to potentially "win big" for 2015.  "Picking five Bay Area companies to watch this year is just as difficult, if only because I'm limiting myself to five," wrote Leuty. "The companies, are there for a batch of reasons — not just because they might turn out a blockbuster drug. In fact, only one is likely to bring a product to market this year." His writes...

HealthTell Announces Receipt of an NIH/NCI Grant to Detect the Presence of Brain Cancer

December 2, 2014

SAN RAMON, Calif.,  -- HealthTell(TM), an early stage Life Sciences company, today announced it has been awarded a $225,000 SBIR grant (1R43CA183360-01) from the National Institutes of Health (NIH) to evaluate the performance of the company's proprietary Immunosignature(TM) Technology in accurately diagnosing brain cancer. This will include the specific diagnosis of glioblastoma multiforme (GBM), the most common and aggressive malignant brain tumor. The project, conducted in...

Biodesign spinout HealthTell, Inc. enters next stage of commercialization efforts

August 20, 2013

HealthTell, Inc., a biotech spinout from Arizona State University, has raised $4 million in new funding over the past few months to help commercialize a new test for lung, breast, prostate and colorectal cancer. “Last year, more than 270,000 Americans died from lung, breast, prostate and colorectal cancers – the top four cancers worldwide,” said Bill Colston, co-founder and CEO of HealthTell. “This $4 million in new funding will help HealthTell demonstrate the ability of its test to...

ASU receives NSF INSPIRE award to accelerate ‘Digital Chemistry’ research

July 24, 2012

Arizona State University has received a $1 million award from the National Science Foundation (NSF) under a new interdisciplinary grant program called INSPIRE. INSPIRE, which stands for Integrated NSF Support Promoting Interdisciplinary Research and Education, was established to address some of the most complicated and pressing scientific problems that lie at the intersections of traditional disciplines. The ASU team, led by Biodesign Institute researcher Neal Woodbury, will pursue...

Research into synthetic antibodies offers hope for new diagnostics

January 24, 2011

Antibodies are watchdogs of human health, continuously prowling the body and registering minute changes associated with infection or disease with astonishing acuity. They also serve as biochemical memory banks, faithfully recording information about pathogens they encounter and efficiently storing this data for later use. Stephen Albert Johnston, Neal Woodbury and their colleagues at the Biodesign Institute at Arizona State University have been exploring mechanisms of antibody activity,...

New technique permits development of enzyme tool kit

May 5, 2010

An Arizona State University graduate student, Jinglin Fu, in collaboration with Biodesign Institute researchers Neal Woodbury and Stephen Albert Johnston, has pioneered a technique that improves on scientists’ ability to harness and modulate enzyme activity.  The new approach, reported in the Journal of the American Chemical Society (published online on Apr. 21st, 2010) , could have wide applicability for designing a range of industrial catalysts, health care diagnostics and therapies...